These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9108812)

  • 21. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
    Miller MJ; Molla PM
    Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J
    Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    Nord J Psychiatry; 2017 Oct; 71(7):496-502. PubMed ID: 28632422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for overweight and diabetes mellitus in residential psychiatric patients.
    Mookhoek EJ; de Vries WA; Hovens JE; Brouwers JR; Loonen AJ
    Obes Facts; 2011; 4(5):341-5. PubMed ID: 22166752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antipsychotics and new onset diabetes.
    Wirshing DA; Spellberg BJ; Erhart SM; Marder SR; Wirshing WC
    Biol Psychiatry; 1998 Oct; 44(8):778-83. PubMed ID: 9798083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Schizophrenia and diabetes mellitus: not an improbable combination].
    Cohen D; Gispen-de Wied CC
    Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of clozapine safety.
    Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
    Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project.
    Kropp S; Grohmann R; Hauser U; Rüther E; Degner D
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S79-83. PubMed ID: 15052518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
    Lund BC; Perry PJ; Brooks JM; Arndt S
    Arch Gen Psychiatry; 2001 Dec; 58(12):1172-6. PubMed ID: 11735847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine.
    Wu G; Dias P; Chun W; Li G; Kumar S; Singh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1395-400. PubMed ID: 11125862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine-associated diabetes.
    Koller E; Schneider B; Bennett K; Dubitsky G
    Am J Med; 2001 Dec; 111(9):716-23. PubMed ID: 11747852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
    Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
    Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
    Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes as a result of atypical anti-psychotic drugs--a report of three cases.
    Rigalleau V; Gatta B; Bonnaud S; Masson M; Bourgeois ML; Vergnot V; Gin H
    Diabet Med; 2000 Jun; 17(6):484-6. PubMed ID: 10975220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on side-effects in treatment of psychoses with clozapine (Leponex)].
    Kirkegaard A; Jensen A
    Ugeskr Laeger; 1977 Nov; 139(47):2800-5. PubMed ID: 595167
    [No Abstract]   [Full Text] [Related]  

  • 40. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.